From bortezomib to other inhibitors of the proteasome and beyond
D Buac, M Shen, S Schmitt, F Rani Kona… - Current …, 2013 - ingentaconnect.com
The cancer drug discovery field has placed much emphasis on the identification of novel
and cancer-specific molecular targets. A rich source of such targets for the design of novel …
and cancer-specific molecular targets. A rich source of such targets for the design of novel …
Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials
Z Huang, Y Wu, X Zhou, J Xu, W Zhu, Y Shu… - Future oncology, 2014 - Taylor & Francis
The ubiquitin–proteasome system is a major pathway for protein degradation, so that
proteasome is now considered as an important target for drug discovery. Bortezomib, the …
proteasome is now considered as an important target for drug discovery. Bortezomib, the …
Programmed cell death pathways and current antitumor targets
Apoptosis and autophagic cell deaths are programmed cell deaths and they play essential
roles in cell survival, growth and development and tumorigenesis. The huge increase of …
roles in cell survival, growth and development and tumorigenesis. The huge increase of …
[HTML][HTML] New advances in targeted gastric cancer treatment
Despite a decrease in incidence over past decades, gastric cancer remains a major global
health problem. In the more recent period, survival has shown only minor improvement …
health problem. In the more recent period, survival has shown only minor improvement …
Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
J Mullenders, R Bernards - Oncogene, 2009 - nature.com
A major impediment to the effective treatment of cancer is the molecular heterogeneity of the
disease, which is also reflected in an equally diverse pattern of clinical responses to therapy …
disease, which is also reflected in an equally diverse pattern of clinical responses to therapy …
Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?
H Wong, T Yau - The oncologist, 2012 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Identify
the subset of advanced gastric cancer patients who might benefit from approved anti-HER2 …
the subset of advanced gastric cancer patients who might benefit from approved anti-HER2 …
Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types
X Ling, D Calinski, AA Chanan-Khan, M Zhou… - Journal of Experimental & …, 2010 - Springer
Background Survivin is known playing a role in drug resistance. However, its role in
bortezomib-mediated inhibition of growth and induction of apoptosis is unclear. There are …
bortezomib-mediated inhibition of growth and induction of apoptosis is unclear. There are …
HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
R Jiang, J Wang, J Liang, D Lin, Q Mao… - Frontiers in …, 2023 - frontiersin.org
Background: Gastric cancer (GC) is a multifactorial progressive disease with high mortality
and heterogeneous prognosis. Effective prognostic biomarkers for GC were critically …
and heterogeneous prognosis. Effective prognostic biomarkers for GC were critically …
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive …
A Jatoi, NR Foster, JR Egner… - International …, 2010 - spandidos-publications.com
Whether elderly patients with metastatic esophageal, gastroesophageal, and gastric cancer
do as well with chemotherapy as their younger counterparts was investigated in this pooled …
do as well with chemotherapy as their younger counterparts was investigated in this pooled …
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
Purpose The transcription factor nuclear factor-kB (NFkB) is implicated in gastric cancer
carcinogenesis and survival, and its inhibition by proteosome inhibition is associated with …
carcinogenesis and survival, and its inhibition by proteosome inhibition is associated with …